Sopharma AD-BG11SOSOBT18-SOPHARMA

SOPHARMA AD (14/2024) Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the acquisition of shares from a temporary issue/exercise of warrants

Report no 14/2024
- 22.02.2024, 10:50
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (13/2024) Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the exercise of warrants in a capital increase under the condition

Report no 13/2024
- 22.02.2024, 10:46
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (12/2024) NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014 for subscribin shares from a temporary issue/exercising warrants

Report no 12/2024
- 20.02.2024, 15:20
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (11/2024) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 as of 20 February 2024 re exercising warrants

Report no 11/2024
- 20.02.2024, 15:16
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (10/2024) Notification from Ognian Donev under Art. 19 of Regulation (EU) 596/2014 for subscribing sharesd form a temporary issue/exercising warrants on 19 February 2024

Report no 10/2024
- 20.02.2024, 11:07
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (9/2024) Notification from Ognian Donev in accordance with art. 19 from Regulation 596/2014 for exercising warrants on 19 February 2024

Report no 9/2024
- 20.02.2024, 11:03
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (8/2024) Notification for Sales revenues for January 2024

Report no 8/2024
- 19.02.2024, 13:05
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (7/2024) Technical error in the Notification under Art. 89t of the Law on Public Offering of Securities published on 26.01.2024

Report no 7/2024
- 31.01.2024, 14:09
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (6/2024) Individual financial report according to IFRS as of 31 December 2023

Report no 6/2024
- 30.01.2024, 13:35
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (5/2024) Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda district, 16 Iliensko shose Str. by exer

Report no 5/2024
- 26.01.2024, 14:18
- Kategoria: Biznes i finanse
- Źródło: ESPI

Relacja z konferencji „Droga do prezydencji: dyskusja o priorytetach zdrowotnych polskiej prezydencji w Radzie UE”

Instytut Spraw Społecznych (1)